Contact SCGE




SCGE Consortium Home   |  About SCGE Toolkit   |  Contact Us   |  Citing the Toolkit   |  License  
ExperimentIndependent validation of Deverman delivery platform using engineered AAVs to deliver CRSIPR/Cas9 to mouse brain
Experiment ConditionArm 1b: BI28 Neuron Specific Promoter, Positive Delivery Control Animals, Males
Assay Description: Identification of of GFP-positive nuclei (green)
Tissue Measured:brain
Cell Type :neuron
Measurement Type:Delivery Efficiency
Record ID15000001452

EditorSaCas9
Delivery System
Delivery System Subtype
Guide
VectorBI28:AAV-GFAP-NLS-GFP-WPRE-synpA-L1-R2;

Model SpeciesMouse
Model NameB6.Cg-Gt(ROSA)26Sor ^ tm9(CAG-tdTomato)Hze/J

Application Method
Application Sitebrain
Dosage0.25E+11 viral genomes/gram for each virus
Injection Frequencyonce
Injection Rate
Injection Volume5 microliters/gram
Days post injection4 weeks
Editor FormatAAV vector encoded
Antidote Id
Antidote Description

Measured Values
Samples Size: 4
 
Replicate Result (Delivery Efficiency)
Measurement Units: Signal
Mean 4 of 4 present 
1 present 
2 present 
3 present 
4 present 
  

Title Description File Download SCGE ID
Heaney_SATC Tissue Processing, Imaging and Analysis Procedure for tissue preparation, imaging and analysis. Heaney_SATC_Tissue_Processing_Imaging_and_Analysis.pdf 21000000025

Publication Title
Cross-species evolution of a highly potent AAV variant for therapeutic gene transfer and genome editing. NCBI